HALIX is a GMP Contract Manufacturing Organization (CMO)
HALIX produces clinical and commercial batches in the biopharmaceutical industry. We are based in Leiden (The Netherlands) and licensed for GMP manufacturing of biopharmaceuticals.
We are a competent partner for biopharmaceutical companies developing and commercializing biologic drug products. We focus on cell culturing of recombinant proteins like monoclonal-, antibodies and viral vaccines. We offer integrated biopharmaceutical development and manufacturing throughout the full pharmaceutical value chain.
HALIX combines world-class, "single point of contact" project management with sound processes and procedures. Analytical and process development support at all stages of drug development and manufacturing. From pre-clinical through commercialization, we enable customers to bring their products to market. Always within the most efficient timeframe possible.
Together with Droege Ventures we apply the SMART (Scale, Money, Acceleration, Resources, Time) principle. This enables future prospects market promising ideas in the field of pharmaceutical product development.
HALIX B.V. is a subsidiary of the family owned HAL Allergy Holding B.V.